the absence of the usual BRR media announcement for the FDA approval of next steps on the inhaled program is also worrying to me. Usually we would have Dr Glass or GC tell us how much of a big deal it is (and it is a big deal).
What they did was separately talk to media.
My interpretation , just mine alone, was that Dr Glass was downbeat and emphasised the huge risk. He gave no indication that any big player was showing interest, instead he said 'you could lose your investment'. He was also very positive on the assets, but i think the article shows frustration at the lack of interest in what he regards as valuable assets.
can they put the breaks on some of the other work? I'm not sure. I'd really like the Nadolol trial to complete.
IVX Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)